🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Canada / NCT07051096
Starting soon Not applicable

Responsive Nature-Driven Imagery to Reduce Delirium After Cardiac Surgery

NCT07051096 · tracked via the Priya Life Science Canada tracker
Phase
Not applicable
Started
2025-09
Last updated
2025-07-03

Condition(s) studied

Delirium - PostoperativeAgitationAnxietyCardiac Surgery Recovery

Investigational drug(s) / intervention(s)

A novel device developed providing nature-driven responsive imagery that responds to the patient's physiological to distract, engage, and de-escalate behaviours of delirium.Routine post-operative management and standard delirium reduction measures.

A novel device developed providing nature-driven responsive imagery that responds to the patient's physiological to distract, engage, and de-escalate behaviours of delirium.: This device will be provided on top of routine post-operative management and standard delirium reduction measures. It has proven effective in a previous clinical trial by reducing agitation and unscheduled medications. It displays nature-driven responsive imagery through an available mobile screen/device for the first 7 days after surgery or discharge, whichever comes first. The imagery adapts in real-time to the participant's movement and sound. The device will be placed at the foot of the bed while the patient is awake and may be interrupted at the discretion of the patient, bedside RN or attending physician.

Routine post-operative management and standard delirium reduction measures.: Examples of routine post-operative care are sleep optimization, avoidance of delirium-promoting medications, orientation, and mobilization.

Study summary

The goal of this clinical trial is to learn if a novel device (MindfulGarden) is beneficial in a population of patients undergoing cardiac surgery. The main questions it aims to answer are:

Is a novel device (MindfulGarden) that uses responsive nature-driven imagery feasible in patients undergoing cardiac surgery? Will use of this device reduce the use of psychotropic medications, improve recovery experience, and improve delirium?

Participants will receive routine post-operative management and standard delirium reduction measures. They will be randomized into two groups where one receives the novel device (MindfulGarden) and the other does not.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Planned open-heart cardiac surgery (e.g. coronary artery bypass grafting, valve replacement surgery); * Able to understand study procedures and provide informed consent in English; * At least one delirium risk factor: 1) Age less than 65yrs; 2) History of delirium; 3) History of stroke/TIA; 4) Known cognitive impairment; 5) Depression requiring medication. Exclusion Criteria: * Severe pre-existing cognitive impairment (Montreal Cognitive Assessment \[MOCA6\]\<10) * Uncorrected visual impairment; * Significant impairment from psychiatric disease; * Enrolment in another clinical trial which may interfere with the study outcome measures.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
St. Paul's Hospital Vancouver British Columbia

More University of British Columbia trials in Canada

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07051096 on ClinicalTrials.gov ↗ ← All trials in Canada